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Synthesis and antiproliferative activity of some steroidal lactams
Yanmin Huang , Jianguo Cui , Sijing Chen , Chunfang Gan , Aimin Zhou
Introduction
Steroidal compounds display a variety of biological functions
and play a very important role in life [1,2]. The steroidal drugs
are widely used in traditional medicines, such as antibacterium,
hormone kind medication, etc. The introduction of heteroatom or
replacement of one or more carbon atoms in steroidal molecule
by a heteroatom affects the chemical properties of the steroidal
molecule and often results in alterations of its biological activities.
The study of natural products which isolated from marine life
showed that the steroidal compounds bearing different functional
groups, such as hydroxyl, hydroximino, hydrazone, sulfate groups,
had excellent cytotoxicity against some tumor cells [3 7].
A variety of steroids with unusual and interesting structures
have been synthesized and evaluated for their anti tumor activity
[8 10]. In order to evaluate the anti tumor activity of new steroi
dal derivatives, we synthesized a series of steroidal oxime deriva
tives and investigated their cytotoxic activity against different
types of cancer cells [11,12]. Interestingly we found that the cyto
toxic activity of a steroidal oxime is dependent on the cholesteric
side chain and function groups at position 3 and 6 on the steroidal
nucleus.
Azahomosteroids are also a class of steroid compounds which
were synthesized and modiﬁed in order to increase biological
activity of steroids. These compounds have been tested success
fully as anti cancer drugs against several types of cancer cells
[13 17]. In order to ﬁnd novel and effective anti tumor agents,
we synthesized a series of 17a aza D Homo andrester 17 one, 3
aza A homo 4 one bile acid and 7 deoxycholic acid derivatives
with various groups on the steroidal nucleus, and the results
showed that these compounds could exhibit a high cytotoxicity
to HeLa tumor cell line in vitro [18,19]. Here, some steroidal com
pounds carrying lactam at A ring and a different active group on
the 6 position of steroidal nucleus were synthesized and evaluated
for their antiproliferative activity against some cancer cells.
Experimental
Chemistry
The sterols and NaBH4 were purchased from the Merck Co. All
chemicals and solvents were analytical grade and solvents were
puriﬁed by general methods before being used. Melting points
were determined on an X4 apparatus and were uncorrected. Infra
red spectra were measured with a Nicolet FT 360 Spectrophotom
eter. The 1H and 13C NMR spectra were recorded in CDCl3 on a
Bruker AV 600 spectrometer at working frequencies 600 and
150 MHz and a Bruker AV 300 spectrometer at working frequen
cies 300 and 75 MHz, respectively. Chemical shifts are expressed
in parts per million (d) values and coupling constants (J) in Hertz.
LREIMS were recorded on a Thermo DSQ instrument. The cell pro
liferation assay was undertaken by a MTT method using 96 well
plates on Biocell ELISA analysis spectrometer.
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(3E) Hydroximinocholest 6 one (1) was prepared according to
procedures in the literature [12].
The synthesis of 4 aza A homocholest 3,6 dione (2) and 3 aza
A homocholest 3,6 dione (3)
The solution of thionyl chloride (2.1 mL) in 5 mL dry THF was
added to a solution of oxime 1 (450 mg, 0.99 mmol) in dry THF
(15 mL). The solution was stirred under anhydrous conditions for
1 h at 0 C. Then the reaction was terminated and water was added
to the solution. The solution was neutralized with ammonia and
the product was extracted with CH2Cl2 (20 3 mL). The combined
extract was washed with water, 5% NaHCO3, and saturated brine,
dried over anhydrous Na2SO4 and evaporated under reduced pres
sure to give a crude product (750 mg) which was chromatographed
on silica gel (elution: petroleum ether (60 90 C)/EtOAc (1:5)) to
give a yellow oily mixture. The oily mixture was further subjected
to chromatography (methanol/dichloromethane (1:20)) to afford
184.8 mg of 4 aza A homocholest 3,7 dione (2) as white crystals,
yield: 45%, hmp 212 213 C; IR(KBr) m/cm1: 3190, 3072, 2950,
2850, 2310, 1711, 1687, 1454, 1380, 816; 1H NMR(CDCl3,
600 MHz) d: 0.671(3H, s, 18 CH3), 0.862(3H, s, 19 CH3), 0.864(3H,
d, J = 6.6, 26 or 27 CH3), 0.868(3H, d, J = 6.6, 26 or 27 CH3),
0.913(3H, d, J = 6.6, 21 CH3), 1.998(1H, t, J = 12.6, C1 aH),
2.054(1H, dt, J = 12.6, 3.6, C7 bH), 2.305(1H, dd, J = 15.0, 7.8, C2
bH), 2.332(1H, dd, J = 13.2, 4.8, C7 aH), 2.415(1H, d, J = 9.6, C5
aH), 2.599(1H, t, J = 13.8, C2 aH), 3.311(1H, ddd, J = 16.2, 9.6, 4.8,
C4a bH), 3.445(1H, ddd, J = 16.2, 7.8, 1.2, C4a aH), 6.007(1H, brt,
J = 4.8, NH); 13C NMR(CDCl3, 150 MHz) d: 210.5(C 6), 178.1(C 3),
61.5(C 5), 56.7(C 14), 56.1(C 17), 53.7(C 9), 46.8(C 7), 44.3(C 13),
42.8(C 10), 39.5(C 12), 38.0(C 8), 36.8(C 4a), 36.1(C 22), 35.7(C
20), 34.8(C 1), 31.2(C 2), 28.00(C 25), 27.99(C 16), 23.9(C 15),
23.8(C 24), 22.8(C 23), 22.7(C 27), 22.5(C 26), 21.5(C 11), 18.6(C
21), 12.9(C 19), 12.0(C 18); ESI MS m/z: 416(M+1)+.
In the reaction, 3 aza A homocholest 3,7 dione (3) (the isomer
of 2) was obtained as a byproduct in 21.5% yield (88 mg), hmp 235
237 C; IR(KBr) m/cm1: 3190, 3072, 2953, 1707, 1679, 1466, 1368;
1H NMR(CDCl3, 600 MHz) d: 0.666(3H, s, 18 CH3), 0.833(3H, s, 19
CH3), 0.860(3H, d, J = 6.6, 26 or 27 CH3), 0.871(3H, d, J = 6.6, 26 or
27 CH3), 0.909(3H, d, J = 6.6, 21 CH3), 2.022(1H, dd, J = 26.4, 13.2,
C7 bH), 2.372(1H, dd, J = 12.6, 4.2, C7 aH), 2.534(1H, dd, J = 13.8,
11.4, C4a bH), 2.600(1H, d, J = 11.4, C4a aH), 2.720(1H, dd, J = 14.4,
2.4, C5 aH), 3.048(1H, dddd, J = 15.6, 7.8, 6.0, 1.8, C2 aH),
3.391(1H, ddd, J = 15.6, 12.0, 4.2, C2 bH), 6.040(1H, brs, NH); 13C
NMR(CDCl3, 150 MHz) d: 209.5(C 6), 177.5(C 3), 56.7(C 14),
56.1(C 17), 54.9(C 5), 54.1(C 9), 46.9(C 7), 44.3(C 13), 42.8(C 10),
41.5(C 12), 39.52(C 1), 39.48(C 24), 38.0(C 8), 37.6(C 2), 36.1(C
22), 35.7(C 20), 30.6(C 4a), 28.00(C 25), 27.99(C 16), 23.9(C 15),
23.8(C 23), 22.8(C 27), 22.6(C 26), 21.8(C 11), 18.6(C 21), 12.9(C
19), 12.0(C 18); ESI MS m/z: 416(M+1)+.
6 Hydroxy 4 aza A homocholest 3 one (4)
To the stirred solution of 2 (100 mg, 0.24 mmol) in CH3OH
(15 mL) was added NaBH4 (30 mg, 0.79 mmol) in one time at room
temperature. After 30 min, the reaction was stopped. The solution
was neutralized with 1 M HCl. After evaporation of the majority of
MeOH under reduced pressure, the residue was extracted with
ethyl acetate (3 15 mL). The organic layer was washed with cold
water and saturated brines. After drying over anhydrous sodium
sulfate, the solvent was removed under reduced pressure and a
crude product (90 mg) was obtained. After crystallization from
methanol, the compound 4 was obtained as a white solid (81 mg,
81%), hmp 228 230 C; IR(KBr) m/cm1: 3411, 2933, 2864, 1662,
1466, 1372, 1262, 1094, 1041, 804; 1H NMR(CDCl3, 600 MHz) d:
0.695(3H, s, 18 CH3), 0.863(3H, d, J = 6.6, 26 or 27 CH3),
0.867(3H, d, J = 6.6, 26 or 27 CH3), 0.906(3H, d, J = 6.6, 21 CH3),
1.144(3H, s, 19 CH3), 2.004(1H, dt, J = 12.6, 3.6, C2 aH), 2.137(1H,
dd, J = 15.0, 1.8, C2 bH), 3.013 2.963(1H, m, C4a bH), 3.038(1H,
dd, J = 14.4, 10.8, C4a aH), 3.420(1H, ddd, J = 15.6, 12.0, 4.2, C6
bH), 3.958(1H, d, J = 1.8, NH), 5.827(1H, brs, OH); 13C
NMR(CDCl3, 150 MHz) d: 178.1(C 3), 73.6(C 6), 56.3 (C 14),
56.1(C 17), 54.0(C 9), 45.8(C 5), 43.5(C 13), 42.4(C 10), 39.9(C
12), 39.8(C 24), 39.5(C 8), 38.8(C 7), 38.1(C 4a), 37.7(C 22),
36.2(C 20), 35.8(C 1), 29.5(C 2), 28.2(C 25), 28.0(C 16), 24.2(C
15), 23.9(C 23), 22.8(C 27), 22.6(C 26), 21.2(C 11), 18.7(C 21),
15.3(C 19), 12.1(C 18); ESI MS m/z: 418(M+1)+.
6 Hydroxy 3 aza A homocholest 3 one (8)
Compound 8was prepared similarly according to the procedure
of 4, but the compound 3 used as starting material instead of the
compound 2. Yield: 90%, hmp 245 247 C; IR(KBr) m/cm1: 3378,
2937, 2868, 1650, 1462, 1380, 1209, 1143, 1094, 1021; 1H
NMR(CDCl3, 600 MHz) d: 0.697(3H, s, 18 CH3), 0.863(3H, d,
J = 6.6, 26 or 27 CH3), 0.867(3H, d, J = 6.6, 26 or 27 CH3),
0.909(3H, d, J = 6.6, 21 CH3), 1.152(3H, s, 19 CH3), 2.270(1H, dd,
J = 15.0, 8.4, C4a aH), 2.634(1H, t, J = 13.2, C2 aH), 2.865(1H, dd,
J = 15.6, 7.8, C2 bH), 3.725(1H, ddd, J = 15.6, 9.3, 4.2, C6 bH),
3.984(1H, d, J = 1.8 Hz, NH), 6.003(1H, brs, OH); 13C NMR(CDCl3,
150 MHz) d: 178.1(C 3), 73.6(C 6), 56.3 (C 14), 56.1(C 17), 54.0(C
9), 45.8(C 5), 43.5(C 13), 42.4(C 10), 39.9(C 12), 39.8(C 24),
39.5(C 8), 38.8(C 7), 38.1(C 4a), 37.7(C 22), 36.2(C 20), 35.8(C 1),
29.5(C 2), 28.2(C 25), 28.0(C 16), 24.2(C 15), 23.9(C 23), 22.8(C
27), 22.6(C 26), 21.2(C 11), 18.7(C 21), 15.3(C 19), 12.1(C 18);
ESI MS m/z: 418 (M+1)+.
6 Hydroximino 4 aza A homocholest 3 one (5)
Compound 2 (100 mg, 0.24 mmol) was dissolved in 10 mL of
95% CH3CH2OH. After the mixture was heated to 60 C, CH3COO
Na3H2O (33 mg, 0.24 mmol) and NH2OHHCl (20 mg, 0.27 mmol)
were added into the solution in 10 min. The mixture was stirred
for 1 h at 60 C. Then reaction was terminated and the majority
of solvent was evaporated under reduced pressure. Distilled water
was added into the reaction mixture, and the product was ex
tracted with ethyl acetate. The combined extract was washed with
saturated brine, dried with anhydrous sodium sulfate and evapo
rated under reduce pressure. The residue was subject to chroma
tography (methanol/dichloromethane (1:20)) to produce 81 mg
of 5 (90%), hmp 243 245 C; IR(KBr) m/cm1: 3321, 3240, 2940,
2864, 1654, 1470, 1380, 968; 1H NMR(CDCl3, 600 MHz) d:
0.650(3H, s, 18 CH3), 0.842(3H, s, 19 CH3), 0.862(3H, d, J = 6.6,
26 or 27 CH3), 0.867(3H, d, J = 6.6, 26 or 27 CH3), 0.898(3H, d,
J = 6.6, 21 CH3), 1.865(1H, dd, J = 15.0, 6.0, C5 aH), 2.001(1H, dt,
J = 12.0, 3.0, C2 aH), 2.333(1H, d, J = 10.8, C8 aH), 2.611(1H, dd,
J = 15.0, 11.4, C2 bH), 3.046(1H, d, J = 13.8, C7 aH), 3.025(1H, dd,
J = 13.8, 6.0, C7 bH), 3.377(1H, dd, J = 13.2, 4.8, C4a aH), 3.419(1H,
ddd, J = 15.0, 11.4, 4.2, C4a bH), 6.193(1H, brs, NH), 9.094(1H,
brs, NOH); 13C NMR(CDCl3, 150 MHz) d: 179.1(C 3), 158.7(C 6),
56.6(C 14), 56.2(C 17), 54.4(C 9), 54.0(C 5), 47.8(C 13), 42.8(C
10), 42.4(C 24), 41.3(C 4a), 39.8(C 12), 39.5(C 7), 37.8(C 8),
36.1(C 22), 35.7(C 20), 31.9(C 1), 29.9(C 2), 28.1(C 25), 28.0(C
16), 24.0(C 15), 23.8(C 23), 22.8(C 27), 22.6(C 26), 21.7(C 11),
18.6(C 21), 12.5(C 19), 12.0(C 18); ESI MS m/z: 431(M+1)+.
. 6 Hydroximino 3 aza A homocholest 3 one (9)
Compound 9was prepared similarly according to the procedure
of 5 using the compound 3 as the starting material. Yield: 81%, hmp
245 257 C; IR(KBr) m/cm1: 3119, 2929, 2859, 1658, 1470, 1381,
1135, 959, 910; 1H NMR(CDCl3, 600 MHz) d: 0.589(3H, s, 18
CH3), 0.799(3H, s, 19 CH3), 0.791(3H, d, J = 6.6 Hz, 26 or 27 CH3),
0.807(3H, d, J = 6.6 Hz, 26 or 27 CH3), 0.834(3H, d, J = 6.6 Hz, 21
CH3), 1.880(1H, dd, J = 13.5, 6.6 Hz, C5 aH), 1.956(1H, m, C2 aH),
2.065(1H, brt, J = 9.0 Hz, C8 aH), 2.167(1H, td, J = 14.4, 7.8 Hz, C8
aH), 2.572(1H, dd, J = 22.8, 13.8 Hz, C2 bH), 3.238(1H, dd, J = 15.6,
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9.6 Hz, C4a aH), 3.296(1H, m, C7 bH), 3.423(1H, dd, J = 15.6, 9.0 Hz,
C4a bH), 6.428(1H, brs, NH), 9.004(1H, brs, NOH); 13C
NMR(CDCl3, 150 MHz) d: 179.6(C 4), 158.9(C 6), 56.5(C 14),
56.0(C 17), 53.9(C 9), 53.7(C 5), 42.6(C 13), 42.1(C 24), 39.6(C
10), 39.4(C 12), 37.9(C 1), 36.0(C 22), 35.7(C 20), 35.6(C 2),
34.4(C 8), 30.7(C 4a), 29.5(C 7), 28.0(C 25), 27.9(C 16), 23.9(C
15), 23.7(C 23), 22.6(C 27), 22.4(C 26), 21.3(C 11), 18.4(C 21),
12.2(C 19), 11.9(C 18); ESI MS m/z: 431(M+1)+.
4 aza A Homocholest 3,6 dione 6 thiosemicarbazone (6)
A mixture of 4 aza A homocholest 3,6 dione (100 mg,
0.249 mmol), thiosemicarbazide (124 mg, 0.5 mmol), and a few
drops of glacial acetic acid (0.5 mL) in 95% ethanol (20 mL) was
stirred at 60 70 C for 2 h. After completion of the reaction, the
majority of solvent was evaporated and some water was added
to this solution. The mixture was extracted with CH2Cl2 and the ex
tract was washed with saturated brine, dried with anhydrous so
dium sulfate and evaporated under reduce pressure. The
resulting residue was chromatographed on a column of silica gel
with a mixture of DCM methanol (20:1) to give compound 6
(91 mg, 72%), hmp 228 230 C; IR(KBr) m/cm1: 3452, 3338, 2941,
2859, 1658, 1580, 1462, 1350, 1221, 1150, 1071, 956; 1H
NMR(CDCl3, 600 MHz) d: 0.665(3H, s, 18 CH3), 0.823(3H, s, 19
CH3), 0.867(3H, d, J = 6.6, 26 or 27 CH3), 0.872(3H, d, J = 6.6, 26
or 27 CH3), 0.907(3H, d, J = 6.6, 21 CH3), 1.975(1H, dd, J = 14.4,
8.4, C5 aH), 2.244(1H, d, J = 9.0, C7 bH), 2.301(1H, ddd, J = 14.4,
6.6, 1.8, C2 bH), 2.597(1H, t, J = 13.8, C1 bH), 2.672(1H, dd,
J = 12.6, 2.4, C2 aH), 3.396(1H, ddd, J = 15.0, 9.6, 4.8, C4a bH),
3.490(1H, dd, J = 15.0, 8.4, C4a aH), 6.082(1H, brs, (C@S) NH),
6.355(1H, brs, (C@S) NH), 7.058(1H, d, J = 4.2, (C@O) NH),
8.756(1H, brs, N NH C); 13C NMR(CDCl3, 150 MHz) d: 179.1(
C@S), 178.4(C 3), 155.5(C 6), 56.4(C 14), 56.1(C 17), 55.5(C 9),
54.1(C 5), 49.4(C 13), 43.2(C 4a), 42.9(C 24), 39.5(C 12), 38.5(C
8), 36.8(C 10), 36.1(C 22), 35.7(C 20), 34.8(C 1), 31.9(C 2),
30.9(C 7), 28.07(C 16), 28.02(C 25), 24.2(C 19), 23.8(C 15),
22.8(C 26), 22.6(C 27), 21.5(C 23), 18.6(C 11), 12.6(C 21), 12.0(C
18); ESI MS m/z: 489.
4 aza A Homocholest 3,6 dione 6 semicarbazone (7)
Compound 7was prepared similarly according to the procedure
of 6, but the semicarbazide used as an attack reagent instead of the
thiosemicarbazide and the reaction mixture was heated at 70
80 C for 6 h. Yield: 62%. hmp 219 220 C; IR(KBr) m/cm1: 3448,
2949, 2868, 1654, 1576, 1470, 1376, 1227; 1H NMR(CDCl3,
600 MHz) d: 0.652(3H, s, 18 CH3), 0.806(3H, s, 19 CH3), 0.866(3H,
d, J = 6.6, 26 or 27 CH3), 0.871(3H, d, J = 6.6, 26 or 27 CH3),
0.902(3H, d, J = 6.6, 21 CH3), 1.880(1H, dd, J = 14.4, 6.0, C7 aH),
2.021(1H, ddd, J = 12.6, 6.0, 3.6, C1 aH), 2.389(1H, d, J = 10.8, C5
aH), 2.656(1H, dd, J = 15.0, 3.6, C2 bH), 2.827(1H, brd, J = 16.2, C2
aH), 3.050(1H, m, C4a bH), 3.387(1H, dd, J = 12.0, 4.2, C4a aH),
4.908(1H, brs, NC(O) NH), 6.021(1H, brs, NC(O) NH),
6.264(1H, d, J = 4.2, (C@O) NH), 7.995(1H, s, N NH C); 13C
NMR(CDCl3, 150 MHz) d: 178.0(C 3), 157.8(C 6), 152.0(
NC(O)NH2), 56.3(C 14), 56.1(C 17), 54.4(C 9), 49.2(C 5), 42.9(C
13), 42.8(C 4a), 41.4(C 10), 39.6(C 12), 39.5(C 24), 37.6(C 8),
36.2(C 2), 36.1(C 22), 35.7(C 20), 32.6(C 1), 31.7(C 7), 28.1(C 16),
28.0(C 25), 24.1(C 19), 23.8(C 15), 22.8(C 26), 22.6(C 27), 21.7(C
23), 18.6(C 11), 12.5(C 21), 12.0(C 18); ESI MS m/z: 473(M+1)+.
Antiproliferative activity
Material and methods
Stock solutions of the compounds were prepared in sterile di
methyl sulfoxide (DMSO) (Sigma) at a concentration of 10 mg/mL
and afterward diluted with complete nutrient medium (RPMI
1640) supplemented with 10% heat inactivated fetal bovine serum
and 0.1 g/L penicillin G + 0.1 g/L streptomycin sulfate.
Cell culture
SMMC 7404 (human liver carcinoma), MGC 7901 (human gas
tric carcinoma), HeLa (human cervical carcinoma) cancer cells
were grown in the medium (RPMI 1640) supplemented with 10%
cosmic calf serum and 0.1 g/L penicillin G + 0.1 g/L streptomycin
sulfate in a humidiﬁed atmosphere of 5% CO2 at 37 C.
Assay for cell viability
The viability of these cells was determined using MTT (3 (4,5
dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide) dye
reduction assay. Brieﬂy, cells (1  104 cells per well) were seeded
in 96 well plates. One day after seeding, the cells were treated with
different concentration of each compound. An equal amount of
DMSO was added to the cells used as negative controls. All were
treated in triplicate. After reincubated for 72 h, the cells were
washed with sterile phosphate buffer saline (PBS). The 190 lL of
RPMI 1640 and 10 lL of the tetrazolium dye (MTT) (5 mg/mL)
solution were added to each well, and the cells were incubated
for an additional 4 h. The medium was discarded and 200 lL of
DMSO was added to dissolve the purple formazan crystals formed.
The absorbance (A) at 492 nm was measured using a Biocell ELISA
analysis spectrometer. The IC50 value was calculated as the concen
tration of drug yielding 50% cell survival. The effect of compounds
on the morphology of treated human carcinoma cells was investi
gated by the light microscope and then photographed by Ni
kon(TE2000 U) inverted microscope.
Results and discussion
Chemistry
Scheme 1 outlines the synthetic procedures of compounds 2 9.
In our previous report [12], compound 1 was obtained in 66.5%
yield by four steps using cholesterol as a starting material. The
structure of compound 1 had been conﬁrmed by its IR and NMR
spectra.
The compounds 2 and 3 were synthesized by Beckmann rear
rangement of 1 with SOCl2/THF at 0 C. In the reaction, the com
pound 2 with 4 aza structure was obtained as a major product in
45% yield. At the same time, the compound 3 with 3 aza structure
was obtained as a byproduct in 21.5% yield. The structures of 2 and
3were conﬁrmed by analysis of the proton and carbon NMR chem
ical shifts at 2 C and 4a C. Resonances showing of C4a bH at
3.311 ppm (ddd, J = 16.2, 9.6 and 4.8 Hz) and C4a aH at
3.445 ppm (ddd, J = 16.2, 7.8, 1.2 Hz) demonstrated a position of
4 NH in the compound 2, while the chemical shifts found for C2
aH at 3.048 ppm (dddd, J = 15.6, 7.8, 6.0, 1.8 Hz) and C2 bH at
3.391 ppm (ddd, J = 15.6, 12.0, 4.2 Hz) were an indicative of the
3 NH in the compound 3. Here, the amide protons produced a cou
pling effect to C4 H in 2 and C2 H in 3, respectively. Moreover, 1H
NMR revealed the presence of the broad singlet at 6.007 ppm in
2 and 6.040 ppm in 3 for the amide proton.
Compounds 4 and 8were obtained by reduction using NaBH4 as
reductant in CH3OH. The structures of compounds 4 and 8were de
duced from its analytical and spectral data. In the 1H NMR spec
trum, the resonances showing of C6 bH at 3.420 ppm (ddd,
J = 15.6, 12.0, 4.2 Hz) and 6 C at 73.6 ppm for 4 and C6 bH at
3.725 ppm (ddd, J = 15.6, 9.3, 4.2 Hz) and 6 C at 73.6 ppm for 8
demonstrated a position of 6 hydroxy respectively. In IR spectrum,
the absorption peaks at 3411 3378 cm1 showed that 6 carbonyl
had been converted to 6 hydroxy in 4 and 8.
1348
1349
Apparently all steroidal lactams (2 9) displayed a distinct cyto
toxicity against these cancer cells. Although the cytotoxic activity
against MGC 7901 and SMMC 7404 cells was not signiﬁcantly
different between 4 N lactam 2 and 3 N lactam 3 or 5 and 9, 3
N lactams showed a higher cytotoxicity against HeLa cells than
4 N lactams. Interestingly 4 N lactam 4 exhibited a high cytotox
icity to all cancer cells tested, but the cytotoxic activity was
remarkably deceased in 3 N lactam 8 although HeLa cells were
sensitive to the compound.
Compounds 2 and 4 7, with same 4 N lactam structure and dif
ferent types of 6 substituted groups, showed a distinct difference
in their cytotoxicity against these cancer cells. The analogs 4 and
5, with a hydroxyl or a hydroximino at C 6, remarkably increased
their cytotoxic activity against MGC 7901 and SMMC 7404 cells
in comparison with the analogs 2 and 7, which have a carbonyl
or semicarbazone groups at C 6. Compounds 6 and 7 with a thio
semicarbazone or semicarbazone groups at C 6 had a better cyto
toxicity than compounds 2, 4 and 5 against HeLa cells. Here
compounds 6, 8, 9 (6: 6.56 lmol/L; 8: 7.76 lmol/L; 9: 5.6 lmol/
L) were even more cytotoxic than cisplatin to HeLa cells (positive
contrast: 10.1 lmol/L).
Conclusion
We have prepared a series of 3 aza A homo 3 oxycholestane
and 4 aza A homo 3 oxycholestane derivatives with different
substituted groups at position 6 of the ring B. The antiproliferative
activity of the synthesized compounds against SMMC 7404, HeLa
and MGC 7901 cancer cells was investigated. All these compounds
displayed a distinct cytotoxicity against these cancer cells. Our
results revealed that the structures of functional groups at posi
tion 6 on the steroidal ring are crucial for the IC50 value of antipro
liferative activities of these compounds and the cytotoxic activity
against MGC 7901 and SMMC 7404 cells was not signiﬁcantly
different between 4 N lactams and 3 N lactams when its 6 substi
tuted group was a carbonyl or a hydroximino, but all 3 N lactams
showed a higher cytotoxicity against HeLa cells than 4 N lactams.
Our ﬁndings could provide new evidence showing the relationship
between the chemical structure and biological activity and may be
useful for the design of novel chemotherapeutic drugs.
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Table 1
In vitro antiproliferative activities (IC50 in lmol/L) of the compounds 2–9.
Compounds Carcinoma cell lines
MGC 7901 HeLa SMMC 7404
2 26.5 42.1 25.3
3 31.8 11.3 28.9
4 15.8 17.2 16.8
5 12.8 22.8 17.6
6 15.3 6.5 40.9
7 36.6 10.6 78.3
8 >100 7.7 77
9 16.3 5.6 17.9
Cisplatin 6.7 10.1 23.2
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